BLC
RGEN icon

Brown, Lisle/Cummings’s Repligen RGEN Stock Holding History

Brown, Lisle/Cummings’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.65K Buy
+31
New +$4.33K ﹤0.01% 723

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Brown, Lisle/Cummings's RGEN Position: Q1 2026 in Review

Brown, Lisle/Cummings opened a new position in Repligen (RGEN) in Q1 2026: 31 shares worth $3.65K. The stake represents ﹤0.01% of the portfolio and ranks #723 among its holdings.

445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Brown, Lisle/Cummings held 31 shares of Repligen worth $3.65K as of Q1 2026.
  • Repligen was a new Brown, Lisle/Cummings position in Q1 2026.
  • Repligen made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #723 holding.
  • 445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.